Sort by
Refine Your Search
-
Listed
-
Field
-
Qualifications: A PhD in biology, neuroscience, development, or a related field. At least one first-author publication. Experience with iPS cells is preferred but not mandatory. Required Application Materials: CV
-
Posted on Tue, 06/17/2025 - 12:47 Important Info Deprecated / Faculty Sponsor (Last, First Name): Eshel, Neir Stanford Departments and Centers: Neuroscience Institute Psyc: Behavioral Medicine
-
the evolution of resistance to anti-cancer therapies. Developmental Cell. doi.org/10.1016/j.devcel.2021.07.009. Required Qualifications: A PhD in biology, genetics, development, neuroscience, or a related field
-
interdisciplinary training in genomics, proteomics, and neuroscience. His research seeks to understand how cellular and synaptic diversity arises during human brain development and evolution, and how these same
-
Drug Screening for Neurodegenerative Diseases Across the Lifespan Stanford Neurology is a world leader in Neuroscience research and clinical care, particularly in the areas of Neurodegeneration, Brain
-
Collaboration on Ecological Neuroscience (SCENE) https://www.simonsfoundation.org/neuroscience/simons-collaboration-on-ecological-neuroscience/ (link is external) SCENE is a 10‑year, USD 80 million initiative
-
Neurosciences at Stanford Medicine. These centers house multiple human MRI research scanners operating at 3 and 7T field strengths, as well as small-bore systems for specimen and animal studies at 7T and 11.7T
-
diseases. The postdoctoral fellow will be joining a young lab with exciting opportunities to make discoveries that intersect ophthalmology and sensory neuroscience. Mentorship and career development is a
-
of Neurology at Stanford University is seeking a highly motivated postdoctoral fellow to join a translational neuroscience research team focused on malignant glioma. This position involves studying tumor
-
, including conference travel and grant-writing experience, within a highly collaborative environment that bridges basic neuroscience and clinical research. In addition to leading the primary neuroimaging trial